Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: Correlation with findings at radical prostatectomy and prognosis

Journal of Urology

Volumn 190, Issue 6, 2013, Pages 2068-2073

  Ellis, Carla L ^a   Partin, Alan W ^a   Han, Misop ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Biopsy; Neoplasm grading; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONSULTATION; DEMOGRAPHY; FAMILY HISTORY; FEMALE; GLEASON SCORE; HUMAN; INSTITUTIONAL REVIEW; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERINEURAL INVASION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; SEMINAL VESICLE; UROLOGIST;

EID: 84888640328     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.05.056     Document Type: Article

References (16)

1. Epstein JI: An update on the Gleason grading system. J Urol 2010;183:433.
2. Humphrey PA: Gleason pattern 5 adenocarcinoma in prostate needle biopsy. J Urol 2012;188:1341.
3. Servoll E, Saeter T, Vlatkovic L et al: Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer. BJU Int May 2011;109:1489.
4. Turker P, Bas E, Bozkurt S et al: Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence free survival. Urol Oncol 2013;31:93.
5. Savdie R, Hovrath L, Benito R et al: High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU Int 2012;109:1794.
6. Epstein JI: The Gleason Grading System: A Complete Guide for Pathologists and Clinicians. Philadelphia: Lippincott Williams & Wilkins 2013.
7. Makarov DV, Trock BJ, Humphreys EB et al: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007;69:1095.
8. Eifler JB, Feng Z, Lin BM et al: An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006-2011. BJU Int 2013;111:22.
9. Sabolch A, Feng F, Daignault-Newton S et al: Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation. Int J Radiat Oncol Biol Phys 2011;81:e351.
10. Nanda A, Chen M, Renshaw A et al: Gleason pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials. Int J Radiat Oncol Biol Phys 2008;74:1419.
11. Carter HB, Walsh PC, Trock BJ et al: Gleason score 6 adenocarcinoma: Should it be labeled as cancer? J Clin Oncol 2012;30:4294.
12. Swanson GP, Yu C, Kattan M et al: Validation of postoperative nomograms in prostate cancer patients with long-term follow-up. Urology 2011;78:105.
13. Kattan MW, Wheeler TM and Scardino PT: Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499.
14. Stephenson AJ, Scardino PT, Eastham JA et al: Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23:7005.
15. Kattan MW, Vickers AJ, Yu C et al: Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer. Cancer 2009;115:1005.
16. Pierorazio PM, Ross AE, Lin BM et al: Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy. BJU Int 2012;110:1122.